85 related articles for article (PubMed ID: 16360886)
21. Impaired regulatory T cell function in germ-free mice.
Ostman S; Rask C; Wold AE; Hultkrantz S; Telemo E
Eur J Immunol; 2006 Sep; 36(9):2336-46. PubMed ID: 16897813
[TBL] [Abstract][Full Text] [Related]
22. Early life exposure to lipopolysaccharide suppresses experimental autoimmune encephalomyelitis by promoting tolerogenic dendritic cells and regulatory T cells.
Ellestad KK; Tsutsui S; Noorbakhsh F; Warren KG; Yong VW; Pittman QJ; Power C
J Immunol; 2009 Jul; 183(1):298-309. PubMed ID: 19542441
[TBL] [Abstract][Full Text] [Related]
23. Induction of eye-derived tolerance does not depend on naturally occurring CD4+CD25+ T regulatory cells.
Keino H; Takeuchi M; Kezuka T; Hattori T; Usui M; Taguchi O; Streilein JW; Stein-Streilein J
Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):1047-55. PubMed ID: 16505040
[TBL] [Abstract][Full Text] [Related]
24. CD4+ICOS+ T lymphocytes inhibit T cell activation 'in vitro' and attenuate autoimmune encephalitis 'in vivo'.
Rojo JM; Pini E; Ojeda G; Bello R; Dong C; Flavell RA; Dianzani U; Portolés P
Int Immunol; 2008 Apr; 20(4):577-89. PubMed ID: 18310064
[TBL] [Abstract][Full Text] [Related]
25. Partial depletion of CD69low-expressing natural regulatory T cells with the anti-CD25 monoclonal antibody PC61.
McNeill A; Spittle E; Bäckström BT
Scand J Immunol; 2007 Jan; 65(1):63-9. PubMed ID: 17212768
[TBL] [Abstract][Full Text] [Related]
26. CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis.
Fletcher JM; Lonergan R; Costelloe L; Kinsella K; Moran B; O'Farrelly C; Tubridy N; Mills KH
J Immunol; 2009 Dec; 183(11):7602-10. PubMed ID: 19917691
[TBL] [Abstract][Full Text] [Related]
27. Frequency of Foxp3+CD4CD25+ T cells is associated with the phenotypes of allergic asthma.
Matsumoto K; Inoue H; Fukuyama S; Kan-O K; Eguchi-Tsuda M; Matsumoto T; Moriwaki A; Nakano T; Nakanishi Y
Respirology; 2009 Mar; 14(2):187-94. PubMed ID: 19192224
[TBL] [Abstract][Full Text] [Related]
28. Blockade of chronic graft-versus-host disease by alloantigen-induced CD4+CD25+Foxp3+ regulatory T cells in nonlymphopenic hosts.
Giorgini A; Noble A
J Leukoc Biol; 2007 Nov; 82(5):1053-61. PubMed ID: 17684039
[TBL] [Abstract][Full Text] [Related]
29. B7+ iris pigment epithelial cells convert T cells into CTLA-4+, B7-expressing CD8+ regulatory T cells.
Sugita S; Keino H; Futagami Y; Takase H; Mochizuki M; Stein-Streilein J; Streilein JW
Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5376-84. PubMed ID: 17122127
[TBL] [Abstract][Full Text] [Related]
30. Downregulation of CD4+CD25+ regulatory T cells may underlie enhanced Th1 immunity caused by immunization with activated autologous T cells.
Cao Q; Wang L; Du F; Sheng H; Zhang Y; Wu J; Shen B; Shen T; Zhang J; Li D; Li N
Cell Res; 2007 Jul; 17(7):627-37. PubMed ID: 17563757
[TBL] [Abstract][Full Text] [Related]
31. Neuroimmunoprotective effects of estrogen and derivatives in experimental autoimmune encephalomyelitis: therapeutic implications for multiple sclerosis.
Offner H
J Neurosci Res; 2004 Dec; 78(5):603-24. PubMed ID: 15515048
[TBL] [Abstract][Full Text] [Related]
32. Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells.
Yan B; Ye S; Chen G; Kuang M; Shen N; Chen S
Arthritis Rheum; 2008 Mar; 58(3):801-12. PubMed ID: 18311820
[TBL] [Abstract][Full Text] [Related]
33. Thymic regulation of autoimmune disease by accelerated differentiation of Foxp3+ regulatory T cells through IL-7 signaling pathway.
Chen X; Fang L; Song S; Guo TB; Liu A; Zhang JZ
J Immunol; 2009 Nov; 183(10):6135-44. PubMed ID: 19841165
[TBL] [Abstract][Full Text] [Related]
34. Function of CD4+,CD25+ Treg cells in MRL/lpr mice is compromised by intrinsic defects in antigen-presenting cells and effector T cells.
Parietti V; Monneaux F; Décossas M; Muller S
Arthritis Rheum; 2008 Jun; 58(6):1751-61. PubMed ID: 18512811
[TBL] [Abstract][Full Text] [Related]
35. The significantly enhanced frequency of functional CD4+CD25+Foxp3+ T regulatory cells in therapeutic dose aspirin-treated mice.
Javeed A; Zhang B; Qu Y; Zhang A; Sun C; Zhang L; Liu J; Zeng C; Zhao Y
Transpl Immunol; 2009 Mar; 20(4):253-60. PubMed ID: 19146957
[TBL] [Abstract][Full Text] [Related]
36. Stem cell reconstitution of autoimmune T cell repertoires.
Edling AE; Tuohy VK
J Neuroimmunol; 2005 Dec; 169(1-2):126-36. PubMed ID: 16199096
[TBL] [Abstract][Full Text] [Related]
37. CD4(+)CD25(+) regulatory T cells contribute to the therapeutic effects of glatiramer acetate in experimental autoimmune encephalomyelitis.
Jee Y; Piao WH; Liu R; Bai XF; Rhodes S; Rodebaugh R; Campagnolo DI; Shi FD; Vollmer TL
Clin Immunol; 2007 Oct; 125(1):34-42. PubMed ID: 17632037
[TBL] [Abstract][Full Text] [Related]
38. Characterization of CD25-positive T cells during syngeneic pregnancy: production of stimulatory class II MHC molecules.
Kyvelidou C; Chatzi K; Semitekolou M; Papathanassiou X; Vassiliadis S; Athanassakis I
Scand J Immunol; 2009 Dec; 70(6):584-95. PubMed ID: 19906201
[TBL] [Abstract][Full Text] [Related]
39. Osteopontin-induced relapse and progression of autoimmune brain disease through enhanced survival of activated T cells.
Hur EM; Youssef S; Haws ME; Zhang SY; Sobel RA; Steinman L
Nat Immunol; 2007 Jan; 8(1):74-83. PubMed ID: 17143274
[TBL] [Abstract][Full Text] [Related]
40. Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.
Ahn JS; Krishnadas DK; Agrawal B
Int Immunol; 2007 Mar; 19(3):227-37. PubMed ID: 17289657
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
